Enzo Biochem Inc
NYSE:ENZ
Enzo Biochem Inc
NYSE:ENZ
Price:
1.04 USD
Market Closed
Updated:
May 4, 2024
Enzo Biochem Inc
Cash from Financing Activities
|
Enzo Biochem Inc
Cash from Financing Activities Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Enzo Biochem Inc
NYSE:ENZ
|
Cash from Financing Activities
-$1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Financing Activities
$83m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Financing Activities
-$1.3B
|
CAGR 3-Years
55%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
0%
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Financing Activities
-$4.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-17%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Financing Activities
-$10.4m
|
CAGR 3-Years
77%
|
CAGR 5-Years
63%
|
CAGR 10-Years
26%
|
See Also
What is Enzo Biochem Inc's Cash from Financing Activities?
Cash from Financing Activities
-1.5m
USD
-1.5m
USD
Based on the financial report for Jan 31, 2024, Enzo Biochem Inc's Cash from Financing Activities amounts to -1.5m USD.
What is Enzo Biochem Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-431%
-431%
Over the last year, the Cash from Financing Activities growth was -431%.
You don't have any saved screeners yet
